Cookies and Tracking Technologies
We use cookies and similar technologies to support the functionality and security of our website, understand website usage, and evaluate the effectiveness of our outreach and marketing efforts. Nothing optional runs until you choose. See our Privacy Notice.
These technologies may collect information such as your IP address, browser and device information, pages visited, and interactions with our website. We may use third-party analytics and advertising services to help us understand website traffic and measure advertising performance.
Because we provide behavioral health services, we take privacy seriously. We do not intend to use this website to collect or disclose information about an individual's health or treatment needs through advertising technologies. We take steps to manage tracking technologies in accordance with applicable privacy requirements.
You can change your choice at any time from "Cookie Preferences" at the bottom of every page. California residents may have additional privacy rights, including the right to opt out of the sale or sharing of personal information. If your browser sends a Global Privacy Control signal, we treat it as that opt-out.
We detected a Global Privacy Control signal from your browser, so advertising cookies stay off.
Most insurance accepted. Click for details
The Alta Mira residential substance use disorder treatment programs were designed by renowned specialists who are among the best in their respective fields.

Executive Clinical Director
Prescription opioid dependence rarely starts with a decision to get high. In 2024, 8 million people in the U.S. aged 12 or older misused a prescription pain reliever, and 70% of them said their main reason was to relieve physical pain [1].
At Alta Mira Recovery, treatment for prescription opioid dependence starts with medically supervised detox, then moves into a residential program built around each client's assessment, pain history, and goals.
For acute pain after surgery or serious injury, prescription opioids provide real relief. The difficulty is that the properties making these medications effective also make them habit-forming. The Centers for Disease Control and Prevention (CDC) advises clinicians to weigh benefits against risks before starting opioids, to prescribe the lowest effective dose, and to keep initial prescriptions for acute pain no longer than the condition requires. The likelihood of long-term use rises with the dose and duration of that first prescription [2].
If two or three of these sound familiar, that is usually enough to signal a problem. Family members often notice the pattern before the person taking the medication does.
Opioids bind to receptors in the brain, spinal cord, and digestive tract, muting pain signals and, for many people, producing a wash of calm. The brain adapts. Receptors become less responsive, the body produces fewer of its own natural opioids, and the original dose stops delivering what it once did.
Only a clinical assessment can tell which one a person is actually facing.
A person can be physically dependent without having an addiction. A person can also have both. Tolerance, dependence, and addiction all require structured clinical care. Sorting out which is which calls for a clinical assessment, not a self-diagnosis.
There is no fixed timeline. Physical dependence can develop within a few weeks of consistent daily use, and the likelihood of prolonged use climbs with higher doses and longer initial prescriptions [2]. Individual factors matter as well, including the type of prescription opioid, a personal or family history of substance use, untreated mental health conditions, and the severity of the underlying pain [3].
These medications share the same underlying mechanism, whatever the brand name:
No version of this class is risk-free. Among people who misused prescription pain relievers in 2024, 43.7% obtained them through a prescription or from a health care provider, and 40.5% had a prescription from a single doctor [1].
When opioids are reduced or stopped abruptly, withdrawal follows. With short-acting medications such as hydrocodone and oxycodone, symptoms typically begin within roughly 8 to 24 hours and can include anxiety, restlessness, insomnia, sweating, muscle aches, abdominal cramping, nausea, and diarrhea. With longer-acting medications, withdrawal starts later and lasts longer [4].
Opioid withdrawal is severe, and it is one of the most common reasons people relapse. There is a further danger in stopping and restarting: tolerance falls quickly during any period of abstinence, so a dose that once felt routine can become an overdose — the same mechanism explored in our look at combined alcohol and opioid withdrawal.
Most people describe withdrawal like a severe flu layered over intense anxiety and an inability to rest. Symptoms generally peak within the first several days and then ease, though disturbed sleep, low mood, and cravings can persist for weeks [4]. Medically supervised withdrawal management makes this phase considerably safer.
People with both opioid addiction and mental health disorders carry a heavy physical and mental load. Research found this group faced a higher likelihood of additional mental health and substance use disorders, opioid overdose, and suicidal thoughts or attempts. Chronic pain and other medical conditions were also more common [5].
Relapse becomes more likely if doctors leave out the underlying mood, trauma, or pain. Alta Mira screens for co-occurring conditions during assessment to build the treatment plan around each client's actual history.
Yes. Any program worth choosing will insist on it. Effective care includes a plan for ongoing pain that does not depend on the substance that created the problem, drawing on non-opioid medication, physical therapy, and approaches that change how pain is processed and experienced.
Care generally begins with medically supervised stabilization, then moves into structured residential treatment.
Not for everyone, but it is often the right call if:
Medical detox removes access, provides medical oversight, and gives the nervous system time to recalibrate.
If you or someone you love has watched a prescription turn into something harder to put down, Alta Mira Recovery offers residential treatment for opioid dependence and complex co-occurring mental health conditions in a private Bay Area setting.
Our credentialed clinical team takes the time to understand your pain history and your mental health before any recommendations and builds the treatment plan around your unique situation.
Related Reading
[1] Substance Abuse and Mental Health Services Administration. 2025, Jul. Key Substance Use and Mental Health Indicators in the United States: Results From the 2024 National Survey on Drug Use and Health. U.S. Department of Health and Human Services.
[2] Dowell, D., Ragan, K.R., Jones, C.M., et al. 2022. CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022. MMWR Recommendations and Reports, 71(3), 1-95.
[3] Dydyk, A.M., Jain, N.K., and Gupta, M. 2024. Opioid Use Disorder: Evaluation and Management. StatPearls Publishing.
[4] Shah, M. and Huecker, M.R. 2023. Opioid Withdrawal. StatPearls Publishing.
[5] Tormohlen, K.N., Mojtabai, R., Seiwell, A., et al. 2021. Co-Occurring Opioid Use and Depressive Disorders: Patient Characteristics and Co-Occurring Health Conditions. Journal of Dual Diagnosis, 17(4), 296-303.
[6] Harris, M.T.H., Weinstein, Z.M., and Walley, A.Y. 2026. Medications for Opioid Use Disorder, Opioid Withdrawal, and Opioid Overdose: A Review. JAMA, 335(11), 986-998.
Medically supervised detox and a pain plan that doesn't depend on the substance that caused the problem.